Patients with a history of pancreatitis, severe gastrointestinal disease, or pregnancy should discuss these factors thoroughly with their provider
Understanding how GLP-1 medications transform the body GLP-1 receptor agonists work through a mechanism that most people dramatically underestimate
In exogenous research applications, the synthetic BPC-157 fragment has been evaluated across tissue types spanning the entire musculoskeletal system, gastrointestinal tract, liver, pancreas, cardiovascular system, and central nervous system producing consistently positive results across an unusually wide range of injury and dysfunction models
Cardiology consultation should be considered for patients with complex cardiovascular disease when questions arise about the appropriateness of continuing GLP-1 therapy in the context of heart rate changes
MHD (aka liscarbazine) is further metabolized via glucuronidation